Patents by Inventor Andreas Oberbach

Andreas Oberbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11147578
    Abstract: The present invention is directed to a method of endoscopically ablating/resecting/excluding (A/R/E) the mucosa of the gastric fundus and body. The method of the present invention is intended to cause cellular death to the X/A-like, ghrelin producing and other hormone cells. This is in contrast to present methods to provide only transient ischemia. The use of the method of the present invention results in a more permanent and robust method of reducing ghrelin and other hormone levels. In addition, a method according to the present invention can be used to induce scarring of the gastric fundus which will reduce gastric accommodation of excess food and result in early satiety.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: October 19, 2021
    Assignee: The Johns Hopkins University
    Inventors: Vivek Kumbhari, Anthony N. Kalloo, Mouen A. Khashab, Andreas Oberbach
  • Publication number: 20170367723
    Abstract: The present invention is directed to a method of endoscopically ablating/resecting/excluding (A/R/E) the mucosa of the gastric fundus and body. The method of the present invention is intended to cause cellular death to the X/A-like, ghrelin producing and other hormone cells. This is in contrast to present methods to provide only transient ischemia. The use of the method of the present invention results in a more permanent and robust method of reducing ghrelin and other hormone levels. In addition, a method according to the present invention can be used to induce scarring of the gastric fundus which will reduce gastric accommodation of excess food and result in early satiety.
    Type: Application
    Filed: December 8, 2015
    Publication date: December 28, 2017
    Inventors: Anthony N. Kalloo, Mouen A. Khashab, Vivek Kumbhari, Andreas Oberbach